Serum tumor necrosis factor alpha associated with acute graft-versus-host disease in humans - PubMed (original) (raw)

Serum tumor necrosis factor alpha associated with acute graft-versus-host disease in humans

F W Symington et al. Transplantation. 1990 Sep.

No abstract available

PubMed Disclaimer

Similar articles

• Serum markers of graft-versus-host disease after bone marrow transplantation.
  Kayaba H, Hirokawa M, Watanabe A, Saitoh N, Changhao C, Yamada Y, Honda K, Kobayashi Y, Urayama O, Chihara J. Kayaba H, et al. J Allergy Clin Immunol. 2000 Jul;106(1 Pt 2):S40-4. doi: 10.1067/mai.2000.106060. J Allergy Clin Immunol. 2000. PMID: 10887332
• Lack of correlation between serum levels and receptor expression of TNF alpha and graft versus host disease following allogeneic bone marrow transplantation.
  Robinet E, Pico JL, Ibrahim A, Ostronoff M, Zambon E, Zohar M, Truneh A, Gay F, Hayat M, Chouaib S. Robinet E, et al. Bone Marrow Transplant. 1991;7 Suppl 2:148. Bone Marrow Transplant. 1991. PMID: 1652325 No abstract available.
• Serum levels and receptor expression of tumor necrosis factor-alpha following human allogeneic and autologous bone marrow transplantation.
  Robinet E, Ibrahim A, Truneh A, Ostronoff M, Mishal Z, Zambon E, Gay F, Hayat M, Pico JL, Chouaib S. Robinet E, et al. Transplantation. 1992 Mar;53(3):574-9. doi: 10.1097/00007890-199203000-00016. Transplantation. 1992. PMID: 1312753
• Lymphokines and the acute-phase response in clinical bone marrow transplantation.
  Cohen J, Bayston K. Cohen J, et al. Eur Cytokine Netw. 1990 Oct-Nov;1(4):251-5. Eur Cytokine Netw. 1990. PMID: 1716489 Review.
• Late complications of allogeneic and autologous marrow transplantation.
  Sullivan KM, Mori M, Sanders J, Siadak M, Witherspoon RP, Anasetti C, Appelbaum FR, Bensinger W, Bowden R, Buckner CD, et al. Sullivan KM, et al. Bone Marrow Transplant. 1992;10 Suppl 1:127-34. Bone Marrow Transplant. 1992. PMID: 1521083 Review. No abstract available.

Cited by

• Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: A Review Based on Physiopathology.
  Milone G, Bellofiore C, Leotta S, Milone GA, Cupri A, Duminuco A, Garibaldi B, Palumbo G. Milone G, et al. J Clin Med. 2022 Jan 26;11(3):623. doi: 10.3390/jcm11030623. J Clin Med. 2022. PMID: 35160072 Free PMC article. Review.
• Approaches for the prevention of graft-versus-host disease following hematopoietic cell transplantation.
  Gatza E, Choi SW. Gatza E, et al. Int J Hematol Oncol. 2015 Aug;4(3):113-126. doi: 10.2217/ijh.15.13. Int J Hematol Oncol. 2015. PMID: 27182433 Free PMC article.
• Disease severity and mortality can be independently regulated in a mouse model of experimental graft versus host disease.
  Galvani RG, Lemos R, Areal RB, Salvador PA, Zamboni DS, Wanderley JL, Bonomo A. Galvani RG, et al. PLoS One. 2015 Feb 2;10(2):e0118079. doi: 10.1371/journal.pone.0118079. eCollection 2015. PLoS One. 2015. PMID: 25643148 Free PMC article.
• Current and emerging strategies for the prevention of graft-versus-host disease.
  Choi SW, Reddy P. Choi SW, et al. Nat Rev Clin Oncol. 2014 Sep;11(9):536-47. doi: 10.1038/nrclinonc.2014.102. Epub 2014 Jun 24. Nat Rev Clin Oncol. 2014. PMID: 24958183 Free PMC article. Review.
• Clinical applications for biomarkers of acute and chronic graft-versus-host disease.
  Levine JE, Paczesny S, Sarantopoulos S. Levine JE, et al. Biol Blood Marrow Transplant. 2012 Jan;18(1 Suppl):S116-24. doi: 10.1016/j.bbmt.2011.10.019. Biol Blood Marrow Transplant. 2012. PMID: 22226094 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.